|
NPHP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.325900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.024800E-01 |
| Normal-vs-Stage2 |
1.614040E-01 |
| Normal-vs-Stage3 |
9.806000E-01 |
| Normal-vs-Stage4 |
8.754600E-01 |
| Stage1-vs-Stage2 |
3.916400E-01 |
| Stage1-vs-Stage3 |
2.011800E-01 |
| Stage1-vs-Stage4 |
6.161400E-01 |
| Stage2-vs-Stage3 |
1.591800E-01 |
| Stage2-vs-Stage4 |
3.591200E-01 |
| Stage3-vs-Stage4 |
8.628000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.194400E-02 |
| Normal-vs-AfricanAmerican |
3.458200E-01 |
| Normal-vs-Asian |
9.113000E-01 |
| Caucasian-vs-AfricanAmerican |
4.165200E-01 |
| Caucasian-vs-Asian |
4.279400E-01 |
| AfricanAmerican-vs-Asian |
5.873600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.313800E-02 |
| Normal-vs-Female |
6.957700E-02 |
| Male-vs-Female |
6.982400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.380800E-01 |
| Normal-vs-Extreme_Weight |
3.753400E-01 |
| Normal-vs-Obese |
1.231620E-01 |
| Normal-vs-Extreme_Obese |
5.804000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.905200E-01 |
| Normal_Weight-vs-Obese |
8.044600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.943600E-01 |
| Extreme_Weight-vs-Obese |
4.606600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.530000E-01 |
| Obese-vs-Extreme_Obese |
6.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.126600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.389740E-02 |
| Normal-vs-Age(61-80Yrs) |
1.849970E-01 |
| Normal-vs-Age(81-100Yrs) |
8.891800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.446400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.020400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.067200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.458170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.223200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.571000E-04 |
| Normal-VS-Type2 PRCC |
8.517600E-02 |
| Normal-VS-KIRP CIMP |
7.724000E-01 |
| Normal-VS-Unclassified PRCC |
2.309800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.33240118727463E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.361800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.754970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.982200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.127590E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.547360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.897800E-01 |
| Normal-vs-N1 |
4.633400E-01 |
| Normal-vs-N2 |
5.105000E-01 |
| N0-vs-N1 |
4.657200E-01 |
| N0-vs-N2 |
5.781200E-01 |
| N1-vs-N2 |
3.360200E-01 |
|
|
